Department of Interventional Pulmonology, Health Sciences University Faculty of Medicine, Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey.
J Surg Oncol. 2020 Nov;122(6):1020-1026. doi: 10.1002/jso.26164. Epub 2020 Aug 11.
Globally, coronavirus disease-2019 (COVID-19) is a new, highly contagious, and life-threatening virus. We aimed to demonstrate how we proceeded with bronchoscopic procedures without published guidelines at the inception of the pandemic period.
All bronchoscopic procedures applied from the first case seen in Turkey (11 March-15 May) were evaluated retrospectively. Patient data on indications, diagnosis, types of procedures, and the results of COVID-19 tests were recorded.
This study included 126 patients; 36 required interventional bronchoscopic techniques (28.6%), 74 required endobronchial ultrasonography (EBUS; 58.7%), and 16 required flexible fiberoptic bronchoscopy (12.7%). All interventional rigid bronchoscopic techniques were performed for emergent indications: malignant airway obstruction (66.7%), tracheal stenosis (25%), and bronchopleural fistula (8.3%). Malignancy was diagnosed in 59 (79.7%), 12 (50%), and 4 (25%) patients who underwent EBUS, interventional procedures, and fibreoptic bronchoscopy, respectively. All personnel wore personal protective equipment and patients wore a surgical mask, cap, and disposable gown. Of the patients, 31 (24.6%) were tested for COVID-19 and all the results were negative. COVID-19 was not detected in any of the patients after a 14-day follow-up period.
This study was based on our experiences and demonstrated that EBUS and/or bronchoscopy should not be postponed in patients with known or suspected lung cancer.
在全球范围内，2019 年冠状病毒病（COVID-19）是一种新型、高度传染性且危及生命的病毒。我们旨在展示在大流行期间，在没有已发表指南的情况下，我们如何进行支气管镜检查。
回顾性评估了土耳其首例病例（2020 年 3 月 11 日至 5 月 15 日）以来所有应用的支气管镜检查。记录了患者的适应症、诊断、操作类型以及 COVID-19 检测结果。
本研究共纳入 126 例患者；36 例需要介入性支气管镜技术（28.6%），74 例需要支气管内超声检查（EBUS；58.7%），16 例需要纤维支气管镜检查（12.7%）。所有介入性硬质支气管镜技术均用于紧急适应症：恶性气道阻塞（66.7%）、气管狭窄（25%）和支气管胸膜瘘（8.3%）。行 EBUS、介入操作和纤维支气管镜检查的患者中，分别有 59 例（79.7%）、12 例（50%）和 4 例（25%）诊断为恶性肿瘤。对 31 例（24.6%）患者进行了 COVID-19 检测，所有结果均为阴性。14 天随访期后，所有患者均未检测到 COVID-19。
本研究基于我们的经验，表明对于已知或疑似肺癌患者，不应推迟进行 EBUS 和/或支气管镜检查。
